Nxera Pharma
4565.T
$5.06
Share price
7.33%
Change (1 day)
-50.40%
Change (1 year)
Categories
EPS for Nxera Pharma (4565.T)
EPS in 2024 (TTM): -$0.80
According to Nxera Pharma's latest financial reports the company's current EPS (TTM) is -$0.80. In 2023 the company made an earnings per share (EPS) of -$0.62 a decrease over its 2022 EPS that were of $0.03577.
EPS history for Nxera Pharma from 2005 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -$0.80 | 28.74% |
| 2023 | -$0.62 | -1829.25% |
| 2022 | $0.03577 | -67.15% |
| 2021 | $0.11 | -40.17% |
| 2020 | $0.18 | 5.97% |
| 2019 | $0.17 | -124.17% |
| 2018 | -$0.71 | -157.64% |
| 2017 | $1.23 | -691.98% |
| 2016 | -$0.21 | -366.52% |
| 2015 | $0.07814 | -74.61% |
| 2014 | $0.31 | 45.12% |
| 2013 | $0.21 | -142.56% |
| 2012 | -$0.50 | 4.42% |
| 2011 | -$0.48 | 18.94% |
| 2010 | -$0.40 | -52.47% |
| 2009 | -$0.84 | -161% |
| 2008 | $1.38 | -205.26% |
| 2007 | -$1.31 | 23.33% |
| 2006 | -$1.07 | 42.13% |
| 2005 | -$0.75 |